![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SEC11A |
Gene summary for SEC11A |
![]() |
Gene information | Species | Human | Gene symbol | SEC11A | Gene ID | 23478 |
Gene name | SEC11 homolog A, signal peptidase complex subunit | |
Gene Alias | 1810012E07Rik | |
Cytomap | 15q25.2-q25.3 | |
Gene Type | protein-coding | GO ID | GO:0006465 | UniProtAcc | P67812 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23478 | SEC11A | EEC-subject3 | Human | Endometrium | EEC | 3.92e-57 | -7.71e-01 | -0.2525 |
23478 | SEC11A | EEC-subject4 | Human | Endometrium | EEC | 2.79e-12 | -4.14e-01 | -0.2571 |
23478 | SEC11A | EEC-subject5 | Human | Endometrium | EEC | 1.95e-06 | -2.81e-01 | -0.249 |
23478 | SEC11A | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 3.94e-43 | -4.11e-01 | -0.1869 |
23478 | SEC11A | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 6.52e-44 | -4.53e-01 | -0.1875 |
23478 | SEC11A | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 4.95e-50 | -3.78e-01 | -0.1883 |
23478 | SEC11A | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 9.83e-33 | -1.95e-01 | -0.1934 |
23478 | SEC11A | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 1.05e-58 | -4.14e-01 | -0.1917 |
23478 | SEC11A | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 3.54e-60 | -4.66e-01 | -0.1916 |
23478 | SEC11A | GSM6177623_NYU_UCEC3_Vis | Human | Endometrium | EEC | 8.09e-14 | -3.77e-01 | -0.1269 |
23478 | SEC11A | LZE2T | Human | Esophagus | ESCC | 2.65e-07 | 1.58e+00 | 0.082 |
23478 | SEC11A | LZE4T | Human | Esophagus | ESCC | 9.34e-25 | 1.01e+00 | 0.0811 |
23478 | SEC11A | LZE5T | Human | Esophagus | ESCC | 2.89e-03 | 7.93e-01 | 0.0514 |
23478 | SEC11A | LZE7T | Human | Esophagus | ESCC | 1.25e-10 | 1.21e+00 | 0.0667 |
23478 | SEC11A | LZE8T | Human | Esophagus | ESCC | 3.45e-11 | 6.08e-01 | 0.067 |
23478 | SEC11A | LZE20T | Human | Esophagus | ESCC | 1.90e-03 | 4.32e-01 | 0.0662 |
23478 | SEC11A | LZE22D1 | Human | Esophagus | HGIN | 1.65e-04 | 3.08e-01 | 0.0595 |
23478 | SEC11A | LZE22T | Human | Esophagus | ESCC | 3.96e-03 | 9.12e-01 | 0.068 |
23478 | SEC11A | LZE24T | Human | Esophagus | ESCC | 2.09e-26 | 8.82e-01 | 0.0596 |
23478 | SEC11A | LZE6T | Human | Esophagus | ESCC | 9.25e-14 | 1.14e+00 | 0.0845 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00064657 | Cervix | CC | signal peptide processing | 8/2311 | 14/18723 | 8.01e-05 | 1.09e-03 | 8 |
GO:00516048 | Cervix | CC | protein maturation | 56/2311 | 294/18723 | 5.90e-04 | 5.59e-03 | 56 |
GO:005160414 | Cervix | N_HPV | protein maturation | 20/534 | 294/18723 | 3.17e-04 | 4.75e-03 | 20 |
GO:00164854 | Cervix | N_HPV | protein processing | 15/534 | 225/18723 | 2.09e-03 | 2.00e-02 | 15 |
GO:000646511 | Cervix | N_HPV | signal peptide processing | 3/534 | 14/18723 | 6.64e-03 | 4.45e-02 | 3 |
GO:0006465 | Colorectum | AD | signal peptide processing | 10/3918 | 14/18723 | 6.90e-05 | 1.11e-03 | 10 |
GO:0051604 | Colorectum | AD | protein maturation | 85/3918 | 294/18723 | 6.73e-04 | 6.91e-03 | 85 |
GO:0016485 | Colorectum | AD | protein processing | 63/3918 | 225/18723 | 6.77e-03 | 4.19e-02 | 63 |
GO:00064652 | Colorectum | MSS | signal peptide processing | 11/3467 | 14/18723 | 1.81e-06 | 5.70e-05 | 11 |
GO:00516042 | Colorectum | MSS | protein maturation | 75/3467 | 294/18723 | 1.70e-03 | 1.53e-02 | 75 |
GO:00164852 | Colorectum | MSS | protein processing | 57/3467 | 225/18723 | 6.60e-03 | 4.38e-02 | 57 |
GO:00064654 | Colorectum | FAP | signal peptide processing | 6/2622 | 14/18723 | 8.21e-03 | 4.82e-02 | 6 |
GO:00516044 | Colorectum | CRC | protein maturation | 47/2078 | 294/18723 | 6.52e-03 | 4.70e-02 | 47 |
GO:00064658 | Endometrium | AEH | signal peptide processing | 6/2100 | 14/18723 | 2.67e-03 | 1.94e-02 | 6 |
GO:000646512 | Endometrium | EEC | signal peptide processing | 6/2168 | 14/18723 | 3.15e-03 | 2.16e-02 | 6 |
GO:005160417 | Esophagus | HGIN | protein maturation | 68/2587 | 294/18723 | 9.77e-06 | 2.86e-04 | 68 |
GO:000646515 | Esophagus | HGIN | signal peptide processing | 8/2587 | 14/18723 | 1.81e-04 | 3.45e-03 | 8 |
GO:00164857 | Esophagus | HGIN | protein processing | 49/2587 | 225/18723 | 7.04e-04 | 9.52e-03 | 49 |
GO:005160418 | Esophagus | ESCC | protein maturation | 189/8552 | 294/18723 | 7.64e-11 | 2.39e-09 | 189 |
GO:001648514 | Esophagus | ESCC | protein processing | 134/8552 | 225/18723 | 1.81e-05 | 1.60e-04 | 134 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0306022 | Cervix | N_HPV | Protein export | 5/349 | 23/8465 | 2.11e-03 | 1.27e-02 | 9.96e-03 | 5 |
hsa0306032 | Cervix | N_HPV | Protein export | 5/349 | 23/8465 | 2.11e-03 | 1.27e-02 | 9.96e-03 | 5 |
hsa03060 | Colorectum | AD | Protein export | 14/2092 | 23/8465 | 2.43e-04 | 1.90e-03 | 1.21e-03 | 14 |
hsa030601 | Colorectum | AD | Protein export | 14/2092 | 23/8465 | 2.43e-04 | 1.90e-03 | 1.21e-03 | 14 |
hsa030602 | Colorectum | MSS | Protein export | 15/1875 | 23/8465 | 1.13e-05 | 1.26e-04 | 7.71e-05 | 15 |
hsa030603 | Colorectum | MSS | Protein export | 15/1875 | 23/8465 | 1.13e-05 | 1.26e-04 | 7.71e-05 | 15 |
hsa0306014 | Endometrium | AEH | Protein export | 11/1197 | 23/8465 | 1.14e-04 | 1.06e-03 | 7.73e-04 | 11 |
hsa0306015 | Endometrium | AEH | Protein export | 11/1197 | 23/8465 | 1.14e-04 | 1.06e-03 | 7.73e-04 | 11 |
hsa0306023 | Endometrium | EEC | Protein export | 11/1237 | 23/8465 | 1.54e-04 | 1.41e-03 | 1.05e-03 | 11 |
hsa0306033 | Endometrium | EEC | Protein export | 11/1237 | 23/8465 | 1.54e-04 | 1.41e-03 | 1.05e-03 | 11 |
hsa0306020 | Esophagus | HGIN | Protein export | 13/1383 | 23/8465 | 1.27e-05 | 1.80e-04 | 1.43e-04 | 13 |
hsa03060110 | Esophagus | HGIN | Protein export | 13/1383 | 23/8465 | 1.27e-05 | 1.80e-04 | 1.43e-04 | 13 |
hsa0306026 | Esophagus | ESCC | Protein export | 22/4205 | 23/8465 | 2.43e-06 | 1.43e-05 | 7.32e-06 | 22 |
hsa0306036 | Esophagus | ESCC | Protein export | 22/4205 | 23/8465 | 2.43e-06 | 1.43e-05 | 7.32e-06 | 22 |
hsa030608 | Liver | Cirrhotic | Protein export | 20/2530 | 23/8465 | 2.00e-08 | 3.51e-07 | 2.17e-07 | 20 |
hsa0306011 | Liver | Cirrhotic | Protein export | 20/2530 | 23/8465 | 2.00e-08 | 3.51e-07 | 2.17e-07 | 20 |
hsa0306021 | Liver | HCC | Protein export | 21/4020 | 23/8465 | 1.20e-05 | 8.53e-05 | 4.74e-05 | 21 |
hsa0306031 | Liver | HCC | Protein export | 21/4020 | 23/8465 | 1.20e-05 | 8.53e-05 | 4.74e-05 | 21 |
hsa0306018 | Oral cavity | OSCC | Protein export | 21/3704 | 23/8465 | 2.42e-06 | 1.27e-05 | 6.45e-06 | 21 |
hsa0306019 | Oral cavity | OSCC | Protein export | 21/3704 | 23/8465 | 2.42e-06 | 1.27e-05 | 6.45e-06 | 21 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SEC11A | SNV | Missense_Mutation | novel | c.361G>C | p.Asp121His | p.D121H | P67812 | protein_coding | deleterious(0.04) | probably_damaging(0.92) | TCGA-HM-A4S6-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
SEC11A | SNV | Missense_Mutation | novel | c.89N>T | p.Ser30Leu | p.S30L | P67812 | protein_coding | deleterious(0.04) | benign(0.221) | TCGA-VS-A9UJ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD |
SEC11A | SNV | Missense_Mutation | novel | c.92N>T | p.Ser31Leu | p.S31L | P67812 | protein_coding | deleterious(0) | possibly_damaging(0.671) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SEC11A | SNV | Missense_Mutation | novel | c.223N>A | p.Asp75Asn | p.D75N | P67812 | protein_coding | tolerated(0.06) | benign(0.209) | TCGA-AX-A06F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
SEC11A | SNV | Missense_Mutation | novel | c.265N>A | p.Gly89Arg | p.G89R | P67812 | protein_coding | deleterious(0) | probably_damaging(0.972) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
SEC11A | SNV | Missense_Mutation | novel | c.152N>C | p.Val51Ala | p.V51A | P67812 | protein_coding | deleterious(0.01) | possibly_damaging(0.841) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SEC11A | SNV | Missense_Mutation | novel | c.199N>T | p.Leu67Phe | p.L67F | P67812 | protein_coding | deleterious(0) | probably_damaging(0.928) | TCGA-B5-A11N-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SEC11A | SNV | Missense_Mutation | novel | c.94N>A | p.Ala32Thr | p.A32T | P67812 | protein_coding | deleterious(0.03) | possibly_damaging(0.779) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
SEC11A | SNV | Missense_Mutation | novel | c.290N>T | p.Arg97Leu | p.R97L | P67812 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-BG-A0VW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SEC11A | SNV | Missense_Mutation | novel | c.402N>T | p.Glu134Asp | p.E134D | P67812 | protein_coding | tolerated(0.2) | benign(0.029) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |